Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,442 | -19,128 | -11,666 | -5,332 | -19,000 |
| Other Working Capital | 4,401 | 2,537 | 1,026 | -210 | 1,895 |
| Other Operating Activity | 6,032 | 4,556 | 3,099 | 1,368 | 4,858 |
| Operating Cash Flow | $-16,009 | $-12,035 | $-7,541 | $-4,174 | $-12,247 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,210 | 30,962 | 17,412 | 16,798 | 12,036 |
| Other Financing Activity | -2,100 | -2,018 | -1,611 | -1,293 | -382 |
| Financing Cash Flow | $29,110 | $28,944 | $15,801 | $15,505 | $11,654 |
| Beginning Cash Position | 18,533 | 18,533 | 18,533 | 18,533 | 19,126 |
| End Cash Position | 31,634 | 35,442 | 26,793 | 29,864 | 18,533 |
| Net Cash Flow | $13,101 | $16,909 | $8,260 | $11,331 | $-593 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,009 | -12,035 | -7,541 | -4,174 | -12,247 |
| Free Cash Flow | -16,009 | -12,035 | -7,541 | -4,174 | -12,247 |